News

(Media Feature) MabGenesis was introduced in Nikkan Kogyo Shimbun

We were introduced in an article in Nikkan Kogyo Shimbun.


(Media Feature) MabGenesis was introduced in Nikkei Biotech

We were introduced in an article in Nikkei Biotech.


Financing received from Miyazaki Taiyo Capital

We received financing from Miyazaki Taiyo Capital Co., Ltd. (Headquarters: Miyazaki City, Miyazaki).


Second round financing completed with multiple investors

We raised 240 MM JPY during a second round of financing from Anniversaire Holdings Inc., Beyond Next Ventures Inc., Miyagin Venture Capital Inc., and SMBC Venture Capital Inc.


Joint research agreement with Gene Techno Science for a new antibody that kills cancer cells

We have concluded a joint research agreement with Gene Techno Science Co., Ltd. (Headquarters: Chuo-ku, Tokyo, President: Masaharu Tani) to obtain an antibody that kills cancer cells…


Seed round financing completed with Beyond Next Ventures Co., Ltd.

Beyond Next Ventures Co., Ltd. underwrote a third-party allotment to raise 37.5 million yen in seed round funding.